(HealthDay)—Even after undergoing the artery-clearing procedure angioplasty, Black patients with heart disease are more likely than whites to suffer a heart attack or die within the next several years.
Jul 6, 2020
0
2
After surveying almost 800 gastroenterology and hepatology patients and their physicians at Penn Medicine, 67% of both viewed their video and telephone appointments held during the peak of the COVID-19 pandemic as positive ...
Jun 25, 2020
0
3
A new study led by researchers at the USC Leonard Davis School of Gerontology is the first to demonstrate that a tiny protein has a big impact on health and longevity in both animals and humans.
Jun 24, 2020
0
73
Patients who received a transplanted liver infected with hepatitis C and were later treated for the infection performed as well in recovery as transplant patients who received an organ free of infection, according to study ...
Jun 23, 2020
0
2
A donated heart can now be transported and preserved for longer than what has previously been possible. The new method, which consists of a specially designed heart box, was used for a transplant for the first time as early ...
Jun 15, 2020
0
17
Patients who go into septic shock are treated with the antihypotensive agent norepinephrine. Researchers from Radboud University Medical Center published results in today's American Journal of Respiratory and Critical Care ...
Jun 12, 2020
0
3
Hospitalized COVID-19 patients at a New York City medical facility had higher rates of kidney complications than other COVID-19 patient groups in different areas of the U.S. and other countries, according to a new study from ...
Jun 9, 2020
0
61
An educational video about hospice care can provide valuable information for patients with advanced cancer and their caregivers, improve perceptions of this quality form of care at the end of life, and increase its use. These ...
Jun 8, 2020
0
4
(HealthDay)—A medication reduction strategy is safe among some older adults treated with antihypertensives, according to a study published in the May 26 issue of the Journal of the American Medical Association.
Jun 3, 2020
0
3
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.
Jun 1, 2020
0
2
